Literature DB >> 26712035

Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells.

Afraa Mamoori1,2, Vinod Gopalan1, Robert Anthony Smith3, Alfred King-Yin Lam1.   

Abstract

There are emerging data to suggest that microRNAs (miRNAs) have significant roles in regulating the function of normal cells and cancer stem cells (CSCs). This review aims to analyse the roles of miRNAs in the regulation of colon CSCs through their interaction with various signalling pathways. Studies showed a large number of miRNAs that are reported to be deregulated in colon CSCs. However, few of the studies available were able to outline the function of miRNAs in colon CSCs and uncover their signalling pathways. From those miRNAs, which are better described, miR-21 followed by miR-34, miR-200 and miR-215 are the most reported miRNAs to have roles in colon CSC regulation. In particular, miRNAs have been reported to regulate the stemness features of colon CSCs mainly via Wnt/B-catenin and Notch signalling pathways. Additionally, miRNAs have been reported to act on processes involving CSCs through cell cycle regulation genes and epithelial-mesenchymal transition. The relative paucity of data available on the significance of miRNAs in CSCs means that new studies will be of great importance to determine their roles and to identify the signalling pathways through which they operate. Such studies may in future guide further research to target these genes for more effective cancer treatment. miRNAs were shown to regulate the function of cancer stem cells in large bowel cancer by targeting a few key signalling pathways in cells.
© 2016 Société Française des Microscopies and Société de Biologie Cellulaire de France. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cancer stem cells; Colon cancer; microRNA

Mesh:

Substances:

Year:  2016        PMID: 26712035     DOI: 10.1111/boc.201500062

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  15 in total

Review 1.  Linking Race, Cancer Outcomes, and Tissue Repair.

Authors:  Jung S Byun; Samson Park; Ambar Caban; Alana Jones; Kevin Gardner
Journal:  Am J Pathol       Date:  2017-11-11       Impact factor: 4.307

Review 2.  Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.

Authors:  María Antonia Lizarbe; Jorge Calle-Espinosa; Eva Fernández-Lizarbe; Sara Fernández-Lizarbe; Miguel Ángel Robles; Nieves Olmo; Javier Turnay
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

3.  Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs.

Authors:  Maria Fragiadaki; Martin P Zeidler
Journal:  J Biol Chem       Date:  2018-04-25       Impact factor: 5.157

4.  Expression profile, molecular functions, and prognostic significance of miRNAs in primary colorectal cancer stem cells.

Authors:  Chuan-Wen Fan; Ran Lu; Chao Fang; Xue-Li Zhang; Zhao-Ying Lv; Yuan Li; Hong Zhang; Zong-Guang Zhou; Xian-Ming Mo; Xiao-Feng Sun
Journal:  Aging (Albany NY)       Date:  2021-04-01       Impact factor: 5.682

5.  miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis.

Authors:  Zhi Chai; Huijie Fan; Yanyan Li; Lijuan Song; Xiaoming Jin; Jiezhong Yu; Yanhua Li; Cungen Ma; Ran Zhou
Journal:  Oncol Rep       Date:  2017-09-26       Impact factor: 3.906

Review 6.  Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis.

Authors:  Yongchen Guo; Yonghua Bao; Wancai Yang
Journal:  Int J Mol Sci       Date:  2017-04-22       Impact factor: 5.923

7.  Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.

Authors:  Sabine Heublein; Markus Albertsmeier; David Pfeifer; Lisa Loehrs; Alexandr V Bazhin; Thomas Kirchner; Jens Werner; Jens Neumann; Martin Kurt Angele
Journal:  BMC Cancer       Date:  2018-02-20       Impact factor: 4.430

8.  miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.

Authors:  Quanbo Ji; Xiaojie Xu; Qi Song; Yameng Xu; Yanhong Tai; Stuart B Goodman; Wenzhi Bi; Meng Xu; Shunchang Jiao; William J Maloney; Yan Wang
Journal:  Mol Ther       Date:  2018-03-14       Impact factor: 11.454

9.  HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial-mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin signaling activation.

Authors:  Wei Tian; Jiatong Li; Zhuo Wang; Tong Zhang; Ying Han; Yanyan Liu; Wenfeng Chu; Yu Liu; Baofeng Yang
Journal:  Acta Pharm Sin B       Date:  2021-04-02       Impact factor: 11.413

Review 10.  Deciphering the role of microRNA 21 in cancer stem cells (CSCs).

Authors:  Durairaj Sekar; Ramalingam Krishnan; Mani Panagal; Pethanen Sivakumar; Vincent Gopinath; Venugopal Basam
Journal:  Genes Dis       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.